OCUGEN, INC. Stock Issued During Period, Value, New Issues
New shares the company issued (share-based compensation, option exercises, employee stock purchase plans, new issues, acquisitions), as filed in its 10-Q and 10-K XBRL statement of shareholders' equity. This is the dilution side; Issuer Repurchases is the other side.
- OCUGEN, INC. stock issued during period, value, new issues for the quarter ending 2026-03-31 was $20.72M.
- OCUGEN, INC. stock issued during period, value, new issues for the quarter ending 2025-09-30 was $18.45M, a 46.88% decline year-over-year.
- OCUGEN, INC. stock issued during period, value, new issues for the quarter ending 2024-09-30 was $34.74M.
- OCUGEN, INC. stock issued during period, value, new issues for the quarter ending 2023-06-30 was $14.77M.
- OCUGEN, INC. stock issued during period, value, new issues for fiscal 2025 was $18.47M, a 48.31% decline from fiscal 2024.
- OCUGEN, INC. stock issued during period, value, new issues for fiscal 2024 was $35.74M, a 75.82% increase from fiscal 2023.
- OCUGEN, INC. stock issued during period, value, new issues for fiscal 2023 was $20.33M, a 64.81% decline from fiscal 2022.
- OCUGEN, INC. stock issued during period, value, new issues for fiscal 2022 was $57.76M.
| Period end | Stock Issued During Period, Value, New Issues 3 month | Stock Issued During Period, Value, New Issues 12 month |
|---|---|---|
| 2026-03-31 | $20.72M 10-Q · filed 2026-08-06 | |
| 2025-12-31 | $18.47M 10-K · filed 2026-03-04 | |
| 2025-09-30 | $18.45M 10-Q · filed 2025-11-05 | |
| 2024-12-31 | $35.74M 10-K · filed 2026-03-04 | |
| 2024-09-30 | $34.74M 10-Q · filed 2025-11-05 | |
| 2023-12-31 | $20.33M 10-K · filed 2025-03-05 | |
| 2023-06-30 | $14.77M 10-Q · filed 2024-11-14 | |
| 2023-03-31 | $5.56M 10-Q · filed 2024-11-14 | |
| 2022-12-31 | $57.76M 10-K · filed 2024-04-16 | |
| 2022-03-31 | $49.85M 10-K · filed 2024-04-16 | |
| 2019-12-31 | $1.00M 10-K · filed 2020-03-27 | |
| 2019-06-30 | $1.95M 10-Q · filed 2020-11-06 | |
| 2018-12-31 | $17.82M 10-K · filed 2019-03-22 | |
| 2018-03-31 | $5.87M 10-Q · filed 2019-08-09 | |
| 2016-12-31 | $26.00K 10-K · filed 2018-03-15 | |
| 2014-12-31 | $56.54M 10-K · filed 2016-03-10 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| Cabaletta Bio, Inc. (CABA) | United States | $0.365B | -2.81 |
| Artiva Biotherapeutics, Inc. (ARTV) | United States | $0.367B | |
| FENNEC PHARMACEUTICALS INC. (FENC) | United States | $0.371B | -115.85 |
| C4 Therapeutics, Inc. (CCCC) | United States | $0.373B | -5.65 |
| Century Therapeutics, Inc. (IPSC) | United States | $0.306B | -4.02 |
| SAB Biotherapeutics, Inc. (SABS) | United States | $0.306B | -25.49 |
| AGENUS INC (AGEN) | United States | $0.383B | 1.41 |
| X4 Pharmaceuticals, Inc (XFOR) | United States | $0.297B | -4.99 |
| Inhibikase Therapeutics, Inc. (IKT) | United States | $0.296B | -4.44 |
| Surrozen, Inc./DE (SRZN) | United States | $0.395B |